目的:系统评价杵针疗法治疗失眠的有效性和安全性。方法:计算机检索中国知网(CNKI)、万方(Wang Fang)、PubMed等数据库中与杵针治疗失眠相关的随机对照研究(RCT),检索时限为建库至2024年1月,使用RevMan 5.4软件对所纳入的文献进行Meta...目的:系统评价杵针疗法治疗失眠的有效性和安全性。方法:计算机检索中国知网(CNKI)、万方(Wang Fang)、PubMed等数据库中与杵针治疗失眠相关的随机对照研究(RCT),检索时限为建库至2024年1月,使用RevMan 5.4软件对所纳入的文献进行Meta分析。结果:最终纳入9项研究,共涉及775例失眠患者,观察组失眠患者390例,对照组385例。观察组治疗失眠的有效率优于对照组[OR = 3.18, 95% CI (2.16, 4.69), P P < 0.00001]。结论:现有证据表明杵针疗法治疗失眠症具有良好的临床疗效,且安全可靠,有助于提高患者的睡眠质量,可在临床中推广应用。展开更多
目的:探讨脑卒中后失眠患者的现状及相关因素对失眠的影响,为防治和护理脑卒中后失眠患者提供相关依据。方法:基于医院住院患者病历系统,选取2023年10月至2024年8月于贵州某三甲医院就诊的120例脑卒中患者作为研究对象,收集脑卒中患者...目的:探讨脑卒中后失眠患者的现状及相关因素对失眠的影响,为防治和护理脑卒中后失眠患者提供相关依据。方法:基于医院住院患者病历系统,选取2023年10月至2024年8月于贵州某三甲医院就诊的120例脑卒中患者作为研究对象,收集脑卒中患者的一般资料、失眠情况及相关疾病情况,采用多因素Logistic回归分析探究脑卒中后失眠的影响因素。结果:研究结果显示120例脑卒中患者的失眠发生率为60.83%,其中高血压[OR = 0.175, 95% CI (0.175, 0.872)]、冠心病[OR = 0.106, 95% CI (0.113, 0.871)]、偏瘫[OR = 4.849, 95% CI (0.439, 53.532)]、失语[OR = 0.322, 95% CI (0.190, 5.414)]是脑卒中失眠的主要影响因素(P Objective: To explore the current situation of post-stroke insomnia patients and the impact of related factors on insomnia, and provide relevant basis for the prevention, treatment and nursing of post-stroke insomnia patients. Method: Based on the hospital's inpatient medical record system, 120 stroke patients who visited a tertiary hospital in Guizhou from October 2023 to August 2024 were selected as the research subjects. General information, insomnia status, and related disease status of stroke patients were collected, and multiple logistic regression analysis was used to explore the influencing factors of post-stroke insomnia. Result: The research results showed that the incidence of insomnia in 120 stroke patients was 60.83%, among which hypertension [OR = 0.175, 95% CI (0.175, 0.872)], coronary heart disease [OR = 0.106, 95% CI (0.113, 0.871)], hemiplegia [OR = 4.849, 95% CI (0.439, 53.532)], and aphasia [OR = 0.322, 95% CI (0.190, 5.414)] were the main influencing factors of insomnia in stroke patients (P < 0.05). Conclusion: Targeted treatment and nursing for risk factors such as hypertension, coronary heart disease, hemiplegia, and aphasia can effectively prevent and improve the sleep quality of stroke insomnia patients and promote disease recovery.展开更多
文摘目的:系统评价杵针疗法治疗失眠的有效性和安全性。方法:计算机检索中国知网(CNKI)、万方(Wang Fang)、PubMed等数据库中与杵针治疗失眠相关的随机对照研究(RCT),检索时限为建库至2024年1月,使用RevMan 5.4软件对所纳入的文献进行Meta分析。结果:最终纳入9项研究,共涉及775例失眠患者,观察组失眠患者390例,对照组385例。观察组治疗失眠的有效率优于对照组[OR = 3.18, 95% CI (2.16, 4.69), P P < 0.00001]。结论:现有证据表明杵针疗法治疗失眠症具有良好的临床疗效,且安全可靠,有助于提高患者的睡眠质量,可在临床中推广应用。
文摘目的:探讨脑卒中后失眠患者的现状及相关因素对失眠的影响,为防治和护理脑卒中后失眠患者提供相关依据。方法:基于医院住院患者病历系统,选取2023年10月至2024年8月于贵州某三甲医院就诊的120例脑卒中患者作为研究对象,收集脑卒中患者的一般资料、失眠情况及相关疾病情况,采用多因素Logistic回归分析探究脑卒中后失眠的影响因素。结果:研究结果显示120例脑卒中患者的失眠发生率为60.83%,其中高血压[OR = 0.175, 95% CI (0.175, 0.872)]、冠心病[OR = 0.106, 95% CI (0.113, 0.871)]、偏瘫[OR = 4.849, 95% CI (0.439, 53.532)]、失语[OR = 0.322, 95% CI (0.190, 5.414)]是脑卒中失眠的主要影响因素(P Objective: To explore the current situation of post-stroke insomnia patients and the impact of related factors on insomnia, and provide relevant basis for the prevention, treatment and nursing of post-stroke insomnia patients. Method: Based on the hospital's inpatient medical record system, 120 stroke patients who visited a tertiary hospital in Guizhou from October 2023 to August 2024 were selected as the research subjects. General information, insomnia status, and related disease status of stroke patients were collected, and multiple logistic regression analysis was used to explore the influencing factors of post-stroke insomnia. Result: The research results showed that the incidence of insomnia in 120 stroke patients was 60.83%, among which hypertension [OR = 0.175, 95% CI (0.175, 0.872)], coronary heart disease [OR = 0.106, 95% CI (0.113, 0.871)], hemiplegia [OR = 4.849, 95% CI (0.439, 53.532)], and aphasia [OR = 0.322, 95% CI (0.190, 5.414)] were the main influencing factors of insomnia in stroke patients (P < 0.05). Conclusion: Targeted treatment and nursing for risk factors such as hypertension, coronary heart disease, hemiplegia, and aphasia can effectively prevent and improve the sleep quality of stroke insomnia patients and promote disease recovery.
